• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p38和MK2激酶级联反应使结节性硬化症2基因产物结节蛋白磷酸化,并增强其与14-3-3的相互作用。

The p38 and MK2 kinase cascade phosphorylates tuberin, the tuberous sclerosis 2 gene product, and enhances its interaction with 14-3-3.

作者信息

Li Yong, Inoki Ken, Vacratsis Panayiotis, Guan Kun-Liang

机构信息

Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor 48109, USA.

出版信息

J Biol Chem. 2003 Apr 18;278(16):13663-71. doi: 10.1074/jbc.M300862200. Epub 2003 Feb 11.

DOI:10.1074/jbc.M300862200
PMID:12582162
Abstract

Tuberous sclerosis complex (TSC) is a genetic disease caused by mutations in either TSC1 or TSC2 tumor suppressor genes. TSC1 and TSC2 (also known as hamartin and tuberin, respectively) form a functional complex and negatively regulate cell growth by inhibiting protein synthesis. 14-3-3 binds to TSC2 and may inhibit TSC2 function. We have reported previously that phosphorylation of serine 1210 (Ser(1210)) in TSC2 is essential for 14-3-3 binding. Here we show that serum and anisomycin enhance the interaction between TSC2 and 14-3-3 by stimulating phosphorylation of Ser(1210). Activation of p38 MAP kinase (p38) is essential for the stimulating effect of serum and anisomycin although p38 is not directly responsible for the phosphorylation of Ser(1210) in TSC2. Both in vitro and in vivo experiments demonstrate that the p38-activated kinase MK2 (also known as MAPKAPK2) is directly responsible for the phosphorylation of Ser(1210). Our data show that anisomycin stimulates phosphorylation of Ser(1210) of TSC2 via the p38-MK2 kinase cascade. Phosphorylation of TSC2 by MK2 creates a 14-3-3 binding site and thus regulates the cellular function of the TSC2 tumor suppressor protein.

摘要

结节性硬化症(TSC)是一种由TSC1或TSC2肿瘤抑制基因发生突变引起的遗传性疾病。TSC1和TSC2(分别也称为错构瘤蛋白和结节蛋白)形成一个功能复合物,并通过抑制蛋白质合成来负向调节细胞生长。14-3-3与TSC2结合并可能抑制TSC2的功能。我们之前报道过,TSC2中丝氨酸1210(Ser(1210))的磷酸化对于14-3-3的结合至关重要。在此我们表明,血清和茴香霉素通过刺激Ser(1210)的磷酸化来增强TSC2与14-3-3之间的相互作用。p38丝裂原活化蛋白激酶(p38)的激活对于血清和茴香霉素的刺激作用至关重要,尽管p38并不直接负责TSC2中Ser(1210)的磷酸化。体外和体内实验均表明,p38激活的激酶MK2(也称为丝裂原活化蛋白激酶激活的蛋白激酶2)直接负责Ser(1210)的磷酸化。我们的数据表明,茴香霉素通过p38-MK2激酶级联反应刺激TSC2的Ser(1210)磷酸化。MK2对TSC2的磷酸化产生一个14-3-3结合位点,从而调节TSC2肿瘤抑制蛋白的细胞功能。

相似文献

1
The p38 and MK2 kinase cascade phosphorylates tuberin, the tuberous sclerosis 2 gene product, and enhances its interaction with 14-3-3.p38和MK2激酶级联反应使结节性硬化症2基因产物结节蛋白磷酸化,并增强其与14-3-3的相互作用。
J Biol Chem. 2003 Apr 18;278(16):13663-71. doi: 10.1074/jbc.M300862200. Epub 2003 Feb 11.
2
14-3-3beta binds to and negatively regulates the tuberous sclerosis complex 2 (TSC2) tumor suppressor gene product, tuberin.14-3-3β与结节性硬化复合物2(TSC2)肿瘤抑制基因产物结节蛋白结合并对其起负调控作用。
J Biol Chem. 2003 Jan 24;278(4):2089-92. doi: 10.1074/jbc.C200499200. Epub 2002 Dec 4.
3
Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase.促肿瘤佛波酯和活化的Ras通过p90核糖体S6激酶使结节性硬化肿瘤抑制复合物失活。
Proc Natl Acad Sci U S A. 2004 Sep 14;101(37):13489-94. doi: 10.1073/pnas.0405659101. Epub 2004 Sep 1.
4
MAPKAP kinase 2 phosphorylates tristetraprolin on in vivo sites including Ser178, a site required for 14-3-3 binding.丝裂原活化蛋白激酶激活的蛋白激酶2在包括Ser178在内的体内位点使锌指蛋白16结合蛋白磷酸化,Ser178是14-3-3结合所需的位点。
J Biol Chem. 2004 Mar 12;279(11):10176-84. doi: 10.1074/jbc.M310486200. Epub 2003 Dec 19.
5
Regulation of TSC2 by 14-3-3 binding.通过14-3-3结合对结节性硬化症复合物2(TSC2)的调控
J Biol Chem. 2002 Nov 22;277(47):44593-6. doi: 10.1074/jbc.C200510200. Epub 2002 Oct 2.
6
Inactivation of the tuberous sclerosis complex-1 and -2 gene products occurs by phosphoinositide 3-kinase/Akt-dependent and -independent phosphorylation of tuberin.结节性硬化症复合物1和2基因产物的失活是通过磷酸肌醇3激酶/蛋白激酶B对结节蛋白的依赖性和非依赖性磷酸化而发生的。
J Biol Chem. 2003 Sep 26;278(39):37288-96. doi: 10.1074/jbc.M303257200. Epub 2003 Jul 16.
7
Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb.结节性硬化症复合基因产物,即结节蛋白和错构瘤蛋白,通过作为Rheb的GTP酶激活蛋白复合物来控制mTOR信号传导。
Curr Biol. 2003 Aug 5;13(15):1259-68. doi: 10.1016/s0960-9822(03)00506-2.
8
Tuberin phosphorylation regulates its interaction with hamartin. Two proteins involved in tuberous sclerosis.结节蛋白磷酸化调节其与错构瘤蛋白的相互作用。这两种蛋白与结节性硬化症有关。
J Biol Chem. 2001 Jun 15;276(24):21017-21. doi: 10.1074/jbc.C100136200. Epub 2001 Apr 4.
9
TSC2 missense mutations inhibit tuberin phosphorylation and prevent formation of the tuberin-hamartin complex.TSC2错义突变抑制结节蛋白磷酸化并阻止结节蛋白-错构瘤蛋白复合物的形成。
Hum Mol Genet. 2001 Dec 1;10(25):2889-98. doi: 10.1093/hmg/10.25.2889.
10
Phosphorylation of tuberin as a novel mechanism for somatic inactivation of the tuberous sclerosis complex proteins in brain lesions.结节性硬化症复合物蛋白在脑损伤中体细胞失活的新机制——结节蛋白的磷酸化
Cancer Res. 2004 Feb 1;64(3):812-6. doi: 10.1158/0008-5472.can-03-3277.

引用本文的文献

1
Mechanically sensitive MAPK signalling mediates resistance exercise-induced muscle growth.机械敏感性丝裂原活化蛋白激酶信号传导介导抗阻运动诱导的肌肉生长。
Nat Metab. 2025 May 15. doi: 10.1038/s42255-025-01303-z.
2
DYRK1A interacts with the tuberous sclerosis complex and promotes mTORC1 activity.DYRK1A 与结节性硬化复合物相互作用并促进 mTORC1 活性。
Elife. 2024 Oct 22;12:RP88318. doi: 10.7554/eLife.88318.
3
Signaling Pathways Leading to mTOR Activation Downstream Cytokine Receptors in Lymphocytes in Health and Disease.信号通路导致健康和疾病中的淋巴细胞下游细胞因子受体的 mTOR 激活。
Int J Mol Sci. 2023 Aug 13;24(16):12736. doi: 10.3390/ijms241612736.
4
Regulation of mTOR Signaling: Emerging Role of Cyclic Nucleotide-Dependent Protein Kinases and Implications for Cardiometabolic Disease.mTOR 信号的调节:环核苷酸依赖性蛋白激酶的新作用及其对心脏代谢疾病的影响。
Int J Mol Sci. 2023 Jul 15;24(14):11497. doi: 10.3390/ijms241411497.
5
Targeting mTOR as a Cancer Therapy: Recent Advances in Natural Bioactive Compounds and Immunotherapy.靶向mTOR作为癌症治疗方法:天然生物活性化合物与免疫疗法的最新进展
Cancers (Basel). 2022 Nov 10;14(22):5520. doi: 10.3390/cancers14225520.
6
Subgroup-Enriched Pathways and Kinase Signatures in Medulloblastoma Patient-Derived Xenografts.成神经管细胞瘤患者来源异种移植物中的亚群富集途径和激酶特征。
J Proteome Res. 2022 Sep 2;21(9):2124-2136. doi: 10.1021/acs.jproteome.2c00203. Epub 2022 Aug 17.
7
G-Protein Coupled Receptor Signaling and Mammalian Target of Rapamycin Complex 1 Regulation.G 蛋白偶联受体信号转导和雷帕霉素靶蛋白复合物 1 调节。
Mol Pharmacol. 2022 Apr;101(4):181-190. doi: 10.1124/molpharm.121.000302. Epub 2021 Dec 28.
8
p38 regulates the tumor suppressor PDCD4 via the TSC-mTORC1 pathway.p38通过TSC-mTORC1信号通路调控肿瘤抑制因子PDCD4。
Cell Stress. 2021 Nov 23;5(12):176-182. doi: 10.15698/cst2021.12.260. eCollection 2021 Dec.
9
AKAP13 couples GPCR signaling to mTORC1 inhibition.AKAP13 将 GPCR 信号传递至 mTORC1 抑制。
PLoS Genet. 2021 Oct 21;17(10):e1009832. doi: 10.1371/journal.pgen.1009832. eCollection 2021 Oct.
10
Regulation of DNA duplication by the mTOR signaling pathway.mTOR 信号通路对 DNA 复制的调控。
Cell Cycle. 2021 Apr;20(8):742-751. doi: 10.1080/15384101.2021.1897271. Epub 2021 Mar 10.